ACHL NASDAQ
Achilles Therapeutics plc
1W: +2.8%
1M: +7.2%
3M: +53.4%
1Y: +14.7%
3Y: -52.9%
$1.48
Last traded 2025-03-24 — delisted
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Balance Sheet Trends
Total Assets
$161M
-26.7% ▼
5Y CAGR: +63.2%
Total Liabilities
$19M
-18.1% ▼
5Y CAGR: +71.5%
Shareholders Equity
$142M
-27.7% ▼
5Y CAGR: +62.2%
Cash & Investments
$132M
-24.1% ▼
5Y CAGR: +65.2%
Total Debt
$5M
-46.2% ▼
Net Debt
-$127M
+23.0% ▲
Assets vs Liabilities & Equity
Year-over-Year Growth
View Full Balance Sheet
| Line Item | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 |
|---|---|---|---|---|---|
| — Assets — | |||||
| Cash | $98M | $178M | $266M | $173M | $132M |
| Short-Term Investments | $0 | $0 | $0 | $0 | $0 |
| Cash & ST Investments | $98M | $178M | $266M | $173M | $132M |
| Net Receivables | $4M | $7M | $11M | $16M | $10M |
| Inventory | $504K | $0 | $5M | $5M | $0 |
| Other Current Assets | $742K | $2M | $2M | $3M | $2M |
| Total Current Assets | $103M | $188M | $285M | $197M | $146M |
| Property, Plant & Equip. | $2M | $28M | $29M | $20M | $14M |
| Goodwill & Intangibles | $0 | $0 | -$33K | -$33K | $0 |
| Long-Term Investments | $0 | $0 | $33K | $33K | $33K |
| Other Non-Current Assets | $34K | $3M | $4M | $3M | $2M |
| Total Non-Current Assets | $2M | $31M | $32M | $24M | $16M |
| Total Assets | $105M | $219M | $317M | $220M | $161M |
| — Liabilities — | |||||
| Accounts Payable | $902K | $6M | $4M | $5M | $6M |
| Short-Term Debt | $0 | $0 | $0 | $0 | $0 |
| Deferred Revenue | $2M | $5M | $10M | $0 | $0 |
| Other Current Liabilities | $2M | $812K | $2M | $2M | $965K |
| Total Current Liabilities | $4M | $17M | $19M | $18M | $17M |
| Long-Term Debt | $0 | $0 | $0 | $0 | $0 |
| Other Non-Current Liab. | $0 | $652K | $691K | $933K | $1M |
| Total Non-Current Liabilities | $0 | $13M | $8M | $5M | $2M |
| Total Liabilities | $4M | $30M | $28M | $23M | $19M |
| — Equity — | |||||
| Common Stock | $14K | $25K | $54K | $54K | $182K |
| Retained Earnings | -$25M | -$58M | -$119M | -$190M | -$260M |
| Accumulated OCI | $8M | $12M | $7M | -$22M | -$13M |
| Total Stockholders Equity | $101M | $189M | $290M | $197M | $142M |
| Total Liabilities & Equity | $105M | $219M | $317M | $220M | $161M |
| — Key Metrics — | |||||
| Total Debt | $487K | $16M | $12M | $9M | $5M |
| Net Debt | -$97M | -$162M | -$254M | -$165M | -$127M |
| Total Investments | $0 | $0 | $33K | $33K | $33K |